Ziopharm Oncology Stock
Your prediction
Ziopharm Oncology Stock
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Ziopharm Oncology stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Ziopharm Oncology in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ziopharm Oncology vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ziopharm Oncology | - | - | - | - | - | - | - |
| Ardelyx Inc. | 28.120% | 34.723% | 18.969% | 89.624% | 39.758% | 44.250% | - |
| Evolus Inc | 10.280% | 12.381% | -5.600% | 60.544% | 30.387% | 60.544% | - |
| Salarius Pharmaceuticals Inc. | 11.650% | 7.981% | 17.949% | -67.606% | -17.117% | -98.248% | -99.993% |